Table 2.
Model with Linear BBBD term | Beta Coefficient | R2 for model | p-value | |
---|---|---|---|---|
Free Water | 0.35 [0.33 to 0.37] |
0.46 | <0.001 | |
FA corrected | 0.34 [0.31 to 0.36] |
0.40 | <0.001 | |
MD corrected | 0.34 [0.31 to 0.37] |
0.40 | <0.001 | |
Model with Quadratic BBBD term | Beta, Linear Term | Beta, Quadratic Term | R2 for model | p-value |
Free Water | 0.57 [0.48 to 0.66] |
−0.040 [-0.056 to −0.025] |
0.47 | <0.001* |
FA corrected | 0.73 [0.60 to 0.86] |
−0.072 [-0.095 to −0.050] |
0.41 | <0.001* |
MD corrected | 0.41 [0.28 to 0.53] |
−0.012 [-0.017 to 0.023] |
0.40 | 0.28 |
Each DTI metric was converted to a Z-score to facilitate comparison across metrics. Separate mixed effects linear regression models were used to predict each mean DTI Z-score across all white matter. All models include covariates for age, sex, race, and MRI site. For each metric, a linear term and a quadratic term for BBBD were tested, and regression coefficients and [95 % confidence intervals] are shown. *Indicates better fit for quadratic over linear model using Wald test with p < 0.001. BBBD: Blood-brain Barrier Disruption; FA: fractional anisotropy; MD: mean diffusivity; CI: confidence interval; Std: Standardized.